COVID-19 patients with hypoxia respond positively to icatibant treatment, Radboud university medical center researchers wrote in JAMA Network Open. These findings have led to a follow-up study at ten Dutch hospitals into ...
Aug 19, 2020
0
6
As more people recover from COVID-19, that means more people should have antibodies against the virus. And it's possible that blood donations from those survivors could help protect or treat other people, according to some ...
Mar 20, 2020
0
36
The COVID-19 pandemic has disrupted the lives of people who use drugs in ways that hurt their mental health and changed drug use behaviors, increasing their risk for overdose, according to surveys and interviews with individuals ...
Apr 26, 2022
0
17
Nursing mothers who received COVID-19 mRNA vaccination experienced adverse events similar to those reported by the general population. COVID-19 vaccination is considered to be safe for nursing mothers and their breastfed ...
Mar 22, 2022
0
7
(HealthDay)—The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the Omicron variant, even though the medication has yet to be given the green light by the ...
Feb 11, 2022
0
12
In December 2020, two novel messenger RNA (mRNA) vaccines for SARS-CoV-2 received emergency use authorization from the U.S. Food and Drug Administration; however, the early trials excluded lactating women, leading to questions ...
Sep 8, 2021
0
2
A survey of more than 17,000 pregnant and lactating individuals who received the COVID-19 vaccine showed that the individuals did not experience symptoms any more severe than their non-pregnant counterparts.
Aug 17, 2021
0
11
Worried or wondering about COVID-19 vaccines?
Feb 22, 2021
0
10
COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. ...
Nov 11, 2020
0
1
With a vaccine for COVID-19 still a long way from being realized, Johns Hopkins immunologist Arturo Casadevall is working to revive a century-old blood-derived treatment for use in the United States in hopes of slowing the ...
Mar 16, 2020
0
5382
